KARL KRUSZYNSKI: Open Payments
NPI 1992810220 · KINGSTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 65 payments from 15 companies in 2025. Trend: 2023 $1,619 · 2024 $2,125 · 2025 $1,626
Food & beverage: $1,337Education: $289
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $385 |
| ABBVIE INC. | 15 | $325 |
| Lilly USA, LLC | 9 | $143 |
| Regeneron Healthcare Solutions, Inc. | 4 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Incyte Corporation | 5 | $117 |
| UCB, Inc. | 3 | $110 |
| Galderma Laboratories, L.P. | 3 | $68 |
| GENZYME CORPORATION | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, TALTZ, RINVOQ, OPZELURA, Bimzelx, COSENTYX.
Industry payments across NY — which companies pay providers there.
